Category Archives: Parkinson’s Treatment

Researchers have characterized the brain complications caused by COVID-19 in people with dementia. Continue reading →

GOTHENBURG, SWEDEN / ACCESSWIRE / May 3, 2023 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, May 3, 2023 - IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company that discovers and develops new treatments for Parkinson's disease, announced today that IRLAB has been made aware that Ipsen's 2022 Universal Registration Document, published on April 6, 2023, contains incorrect information that the development and commercialization rights for mesdopetam have been transferred back to IRLAB. This is not correct. Collaborative discussions regarding mesdopetam's further development path are ongoing Continue reading →

The Andrews University Speech-Language & Hearing Clinic was recently awarded a SPEAK OUT! Therapy and Research Center Grant by the Parkinson Voice Project. The Andrews University Speech-Language & Hearing Clinic was recently awarded a SPEAK OUT! Therapy and Research Center Grant by the Parkinson Voice Project. Valued at more than $280,000, the award provides extensive training and services offered by the nonprofit Parkinson Voice Project over the next five years, including $10,000 per year for resources over the same period Continue reading →

Ted Williams| Writers on the Range Shortly after World War II, California fish managers had a brainstorm: They loaded juvenile trout into airplanes and saturation-bombed naturally fishless lakes in the High Sierra Mountains of California. Some of the fish hit rocks and ice, but most hit water Continue reading →

Health News Roundup: US FDA declines to approve AbbVie's Parkinson's disease therapy; China OKs its first mRNA vaccine, from drugmaker CSPC and more   Devdiscourse Continue reading →

ANNOVIS BIO ANNOUNCES TWO PRESENTATIONS AT THE AD/PD 2023 INTERNATIONAL CONFERENCE ON ALZHEIMER'S AND PARKINSON'S DISEASES   Marketscreener.com Continue reading →

ACORDA THERAPEUTICS INC Management's Discussion and Analysis of Financial Condition and Results of Operations. Continue reading →

With medical marijuana now legalized in 38 states and the District of Columbia, there is strong interest in its therapeutic properties. Researchers are testing marijuana, which is also called cannabis, as a treatment for many illnesses and diseases, including Parkinson's disease (PD). Continue reading →

There is no one-size-fits all treatment for Parkinsons. Rather, treatment should be tailored to an individuals symptoms via a shared decision-making process with your healthcare provider Continue reading →

The concept of 'idiopathic' Parkinson's disease (PD) as a single entity has been challenged with the identification of several clinical subtypes, pathogenic genes and putative causative environmental agents. In addition to classic motor symptoms, non-motor manifestations (such as rapid eye movement sleep disorder, anosmia, constipation and depression) appear at prodromic/premotor stage and evolve, along with cognitive impairment and dysautonomia, as the disease progresses, often dominating the advanced stages of the disease. The key molecular pathogenic mechanisms include -synuclein misfolding and aggregation, mitochondrial dysfunction, impairment of protein clearance (associated with deficient ubiquitin-proteasome and autophagy-lysosomal systems), neuroinflammation and oxidative stress. Continue reading →